These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7047466

  • 21. [Prevalence of chronic diabetes complications depending on the method of insulin therapy in children and adolescents with type 1 diabetes].
    Florys B, Ołdytowska A, Głowińska B, Peczyńska J, Urban M.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):31-9. PubMed ID: 15355737
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical manifestations and beta cell function in Swedish diabetic children have remained unchanged during the last 25 years.
    Nordwall M, Ludvigsson J.
    Diabetes Metab Res Rev; 2008 Sep; 24(6):472-9. PubMed ID: 18613248
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. C-peptide antibodies induced by bovine insulin therapy.
    Reeves WG, Douglas CA.
    Clin Exp Immunol; 1982 Oct; 50(1):171-7. PubMed ID: 6756729
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Insulin resistance: definition and treatment.
    Roffman DS, Wiser TH.
    Am J Hosp Pharm; 1980 Aug; 37(8):1105-10. PubMed ID: 6773414
    [Abstract] [Full Text] [Related]

  • 28. Insulin antibody formation. I. The influence of age, sex, infections, insulin dosage and regulation of diabetes.
    Andersen OO.
    Acta Endocrinol (Copenh); 1972 Sep; 71(1):126-40. PubMed ID: 4678008
    [No Abstract] [Full Text] [Related]

  • 29. [Factors affecting the antigenicity of exogenous insulin in diabetics].
    Penchev II, Taneva T, Ditsov S, Andreev D.
    Vutr Boles; 1985 Sep; 24(1):113-9. PubMed ID: 3895740
    [Abstract] [Full Text] [Related]

  • 30. HLA-types, C-peptide and insulin antibodies in juvenile diabetics [proceedings].
    Ludvigsson J, Heding L, Säfwenberg J.
    Diabete Metab; 1976 Sep; 2(3):158. PubMed ID: 1010130
    [No Abstract] [Full Text] [Related]

  • 31. C-peptide in children with juvenile diabetes. A preliminary report.
    Ludvigsson J, Heding LG.
    Diabetologia; 1976 Dec; 12(6):627-30. PubMed ID: 1001852
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Different insulin antibody formation in diabetic patients treated with crystallized or highly purified insulins is a transient phenomenon.
    Keilacker H, Rjasanowski I, Woltanski KP, Kohnert KD, Ziegler M, Michaelis D.
    Horm Metab Res; 1989 Jul; 21(7):398-9. PubMed ID: 2777200
    [No Abstract] [Full Text] [Related]

  • 40. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins.
    Gray RS, Borsey DQ, Fraser DM, Kurtz AB, Rainbow S, Smith AF, Duncan LJ, Clarke BF.
    Diabetologia; 1981 Sep; 21(3):206-10. PubMed ID: 7028552
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.